Greenlight Biosciences Hldgs Pbc (GRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,055 | -112,310 | -3 | N/A | N/A |
| Depreciation Amortization | 8,076 | 5,772 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -6,612 | 3,697 | N/A | N/A | N/A |
| Other Working Capital | 8,406 | 10,522 | 3 | N/A | N/A |
| Other Operating Activity | 20,454 | 487 | 0 | 0 | 0 |
| Operating Cash Flow | $-136,731 | $-91,832 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26,510 | -15,039 | N/A | N/A | N/A |
| Investing Cash Flow | $-26,510 | $-15,039 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100,293 | 48,833 | N/A | N/A | N/A |
| Debt Repayment | -7,228 | -2,427 | N/A | N/A | N/A |
| Common Stock Issued | 107,786 | 143 | 25 | N/A | N/A |
| Other Financing Activity | 0 | -3,018 | 132 | 0 | 0 |
| Financing Cash Flow | $200,851 | $43,531 | $157 | $N/A | $N/A |
| Beginning Cash Position | 31,808 | 95,148 | N/A | N/A | N/A |
| End Cash Position | 69,418 | 31,808 | 157 | N/A | N/A |
| Net Cash Flow | $37,610 | $-63,340 | $157 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,731 | -91,832 | N/A | N/A | N/A |
| Capital Expenditure | -26,547 | -15,148 | N/A | N/A | N/A |
| Free Cash Flow | -163,278 | -106,980 | 0 | 0 | 0 |